ARE BOTH ASPIRIN AND HEPARIN JUSTIFIED AS ADJUNCTS TO THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION

被引：47

作者：

RIDKER, PM

HEBERT, PR

FUSTER, V

HENNEKENS, CH

机构：

[1] BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02115 USA

[2] BRIGHAM & WOMENS HOSP, DEPT PREVENT MED, BOSTON, MA 02115 USA

[3] MASSACHUSETTS GEN HOSP, DEPT MED, BOSTON, MA 02114 USA

[4] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA

来源：

LANCET | 1993年 / 341卷 / 8860期

关键词：

D O I：

10.1016/0140-6736(93)90707-N

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1574 / 1577

页数：4

相关论文

共 21 条

[1] [Anonymous], 1988, LANCET, V2, P349
[2] [Anonymous], 1990, Lancet, V336, P65
[3] EFFECT OF HEPARIN ON CORONARY ARTERIAL PATENCY AFTER THROMBOLYSIS WITH TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
BLEICH, SD
NICHOLS, TC
SCHUMACHER, RR
COOKE, DH
TATE, DA
TEICHMAN, SL
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (20) : 1412 - 1417
[4] COL J, 1992, CIRCULATION, V86, P259
[5] DEBONO DP, 1992, BRIT HEART J, V67, P122
[6] GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
GUNNAR, RM
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (02) : 249 - 292
[7] A COMPARISON BETWEEN HEPARIN AND LOW-DOSE ASPIRIN AS ADJUNCTIVE THERAPY WITH TISSUE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION
HSIA, J
HAMILTON, WP
KLEIMAN, N
ROBERTS, R
CHAITMAN, BR
ROSS, AM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (21) : 1433 - 1437
[8] HUNT D, 1992, LANCET, V339, P753
[9] CUMULATIVE ANTIPLATELET EFFECT OF LOW-DOSE ENTERIC COATED ASPIRIN
JAKUBOWSKI, JA
STAMPFER, MJ
VAILLANCOURT, R
DEYKIN, D
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (04) : 635 - 642
[10] DO THE RESULTS OF RANDOMIZED CLINICAL-TRIALS OF CARDIOVASCULAR DRUGS INFLUENCE MEDICAL-PRACTICE
LAMAS, GA
PFEFFER, MA
HAMM, P
WERTHEIMER, J
ROULEAU, JL
BRAUNWALD, E
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (04) : 241 - 247